A new tool may help support optometrist and ophthalmologist decisions as they develop care plans for adolescents with amblyopia.

Cardiovascular disease risk factor associations with social determinants of health vary significantly by nativity among Black US adults.

Veterans with narcolepsy type 1 or other narcolepsy face elevated risk for all-cause mortality compared with a general sleep clinic cohort.

A stroke metabolite score comprising 4 validated metabolites improves ischemic stroke risk prediction beyond traditional risk factors in women.

The FDA has approved the oral antiviral Xocova (ensitrelvir) for postexposure prophylaxis of COVID-19 in adults and adolescents.

Patients with Gaucher disease type 1 face high age-specific prevalence of Parkinson disease and possible parkinsonian syndrome by age 80 years.

Among children with enuresis, problematic media use is associated with sleep disturbances and poor sleep hygiene.

HealthDay News — During the first three years of the COVID-19 pandemic, more optimal cardiovascular health (CVH) was associated with a lower risk for severe COVID-19 events, according to a study ...

The FDA has extended the PDUFA date for Beren Therapeutics’ adrabetadex New Drug Application to November 17, 2026, to allow for the review of additional data updates for infantile-onset Niemann-Pick ...

Natalizumab demonstrates sustained long-term safety and efficacy for treating relapsing-remitting multiple sclerosis through 15 years of follow-up.

High basal ganglia perivascular space burden independently predicts long-term cognitive decline in executive function among older adults.

A consolidated single-infusion regimen of ublituximab demonstrated comparable drug exposure, safety, and efficacy outcomes to the currently approved regimen in adults with relapsing forms of multiple ...